Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy (Q33403231)

26 July 2017

1 reference

title

Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy (English)

1 reference

26 July 2017

1 reference

1 reference

1

Daniela Bruttomesso

1 reference

26 July 2017

Silvana Costa

2

1 reference

PubMed ID

19172576

26 July 2017

Aldo Baritussio

series ordinal

3

1 reference

26 July 2017

1 February 2009

1 reference

Diabetes - Metabolism: Research and Reviews

26 July 2017

1 reference

26 July 2017

25

1 reference

26 July 2017

2

1 reference

26 July 2017

99-111

1 reference

Sensor-augmented pump therapy in type 1 diabetes

26 July 2017

1 reference

Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin.

21 January 2018

1 reference

Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic

21 January 2018

1 reference

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

21 January 2018

1 reference

A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series

21 January 2018

1 reference

Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus

21 January 2018

1 reference

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia

21 January 2018

1 reference

7 January 2021

Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump

1 reference

7 January 2021

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes

1 reference

7 January 2021

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

1 reference

7 January 2021

Insulin pump therapy: a meta-analysis

1 reference

7 January 2021

Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy

1 reference

7 January 2021

A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.

1 reference

7 January 2021

A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy

1 reference

7 January 2021

A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump

1 reference

7 January 2021

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study

1 reference

7 January 2021

Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis

1 reference

7 January 2021

Precipitation of insulin aspart and insulin glulisine products used for continuous subcutaneous insulin infusion.

1 reference

7 January 2021

Comparison of in vitro stability for insulin aspart and insulin glulisine during simulated use in insulin pumps.

1 reference

7 January 2021

In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.

1 reference

7 January 2021

Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.

1 reference

7 January 2021

Insulin treatment in diabetic pregnancy

1 reference

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

1 reference

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

1 reference

7 January 2021

1 reference

7 January 2021

Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump.

1 reference

7 January 2021

Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.

1 reference

7 January 2021

Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes

1 reference

7 January 2021

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

1 reference

7 January 2021

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

1 reference

7 January 2021

A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.

1 reference

7 January 2021

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

1 reference

7 January 2021

Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

1 reference

7 January 2021

A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes

1 reference

7 January 2021

Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

1 reference

7 January 2021

Implementation of treatment protocols in the Diabetes Control and Complications Trial

1 reference

7 January 2021

Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life

1 reference

7 January 2021

Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control

1 reference

7 January 2021

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial

1 reference

7 January 2021

A review of human and analogue insulin trials

1 reference

7 January 2021

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes

1 reference

7 January 2021

Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.

1 reference

7 January 2021

Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes

1 reference

7 January 2021

Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience

1 reference

7 January 2021

Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes.

1 reference

7 January 2021

Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.

1 reference

7 January 2021

Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues

1 reference

7 January 2021

Technical risks with subcutaneous insulin infusion.

1 reference

7 January 2021

Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion

1 reference

7 January 2021

Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems

1 reference

7 January 2021

Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients

1 reference

7 January 2021

Pediatric pumps: barriers and breakthroughs

1 reference

7 January 2021

The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes.

1 reference

7 January 2021

Cost-utility analysis of insulin pumps compared to multiple daily doses of insulin in patients with type 1 diabetes mellitus in Spain

1 reference

7 January 2021

Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.

1 reference

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia

1 reference

7 January 2021

Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences

1 reference

7 January 2021

Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women

1 reference

7 January 2021

[Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy]

1 reference

7 January 2021

Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials

1 reference

7 January 2021

Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy

1 reference

7 January 2021

Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions

1 reference

7 January 2021

Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus

1 reference

7 January 2021

Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study

1 reference

7 January 2021

Blood ketone monitoring: a comparison between gestational diabetes and non-diabetic pregnant women.

1 reference

7 January 2021

Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus

1 reference

7 January 2021

Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community

1 reference

7 January 2021

Resource utilization and costs of care in the diabetes control and complications trial

1 reference

7 January 2021

Recent advances in treatment of youth with Type 1 diabetes: better care through technology

1 reference

7 January 2021

Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes,

1 reference

7 January 2021

Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.

1 reference

7 January 2021

Durability of insulin pump use in pediatric patients with type 1 diabetes.

1 reference

7 January 2021

Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.

1 reference

7 January 2021

Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years

1 reference

7 January 2021

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial

1 reference

7 January 2021

A randomized, controlled study of insulin pump therapy in diabetic preschoolers.

1 reference

7 January 2021

Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion

1 reference

7 January 2021

A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes

1 reference

7 January 2021

Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection

1 reference

7 January 2021

Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents.

1 reference

7 January 2021

Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents

1 reference

7 January 2021

Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus

1 reference

7 January 2021

Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin

1 reference

7 January 2021

Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus

1 reference

7 January 2021

Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy

1 reference

7 January 2021

Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion

1 reference

7 January 2021

Neonatal diabetes mellitus: Insulin pump as an alternative management strategy.

1 reference

7 January 2021

Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.

1 reference

7 January 2021

Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events.

1 reference

7 January 2021

Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment

1 reference

7 January 2021

Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas

1 reference

7 January 2021

Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients.

1 reference

7 January 2021

Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure.

1 reference

7 January 2021

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study

1 reference

7 January 2021

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

1 reference

7 January 2021

Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetes.

1 reference

7 January 2021

Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service.

1 reference

7 January 2021

Efficacy of continuous subcutaneous insulin infusion (CSII) in patients with classical contraindications to its use.

1 reference

7 January 2021

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.931

1 reference

26 July 2017

1 reference

PubMed ID

19172576